Replies to post #109037 on Biotech Values

[DewDiligence]

Xarelto vs Pradaxa—one more point for the former is ROCKET-AF was a double blind trial whereas RELY was an open label one.

I give Bayer/JNJ credit for running a double-blind trial where only one of the arms got warfarin. It must have been hard to convince the IRB’s that it was ethical to conduct sham warfarin-like monitoring in the Xarelto arm.